AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BLACKSTONE MINERALS LTD

0.061

-0.003-4.69%

Volume:89.99K

Turnover:5.62K

Market Cap:41.27M

PE:-2.96

High:0.063

Open:0.062

Low:0.061

Close:0.064

Loading ...

Overview Company News Filings

Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions

THOMSON REUTERS

Blackstone Minerals Ltd-Accelerated Non-Renounceable Entitlement Offer Results

THOMSON REUTERS

Boston Scientific to Buy Intera Oncology

MT Newswires Live

BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX

Boston Sci stock climbs 5% on positive Watchman FLX data

Blackstone Credit & Insurance Closed-End Funds Announce Trustee, Officer, and Portfolio Management Team Changes

THOMSON REUTERS

Boston Scientific Completes Acquisition of Axonics

MT Newswires Live

Axonics gains after Nasdaq delisting notice for sale to Boston Scientific

Q3 2024 Black Stone Minerals LP Earnings Call

Thomson Reuters StreetEvents

Boston Scientific to Acquire Medical Technology Firm Cortex

MT Newswires Live

QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel

BRIEF-Blackstone Minerals Launches A$4M Accelerated Entitlement Offer

Blackstone Minerals Ltd-Entitlement Offer Prospectus

THOMSON REUTERS

Blackstone Minerals - All Currencies Represented in AUD

THOMSON REUTERS

PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis

BRIEF-Blackstone Minerals Seeks Trading Halt

Sector Update: Health Care Stocks Retreat in Afternoon Trading

MT Newswires Live

Boston Scientific Gets FDA Approvals for 2 New Cardiac Mapping Technologies

MT Newswires Live

Oppenheimer buy-rated ideas: BSX, MDT, and one hold: CYTK

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BSX.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BSX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSX.AU\",,,,,undefined,":{"symbol":"BSX.AU","market":"AU","secType":"STK","nameCN":"BLACKSTONE MINERALS LTD","latestPrice":0.061,"timestamp":1745388720000,"preClose":0.064,"halted":0,"volume":89992,"delay":0,"nameEN":"BLACKSTONE MINERALS LTD","floatShares":455794853,"shares":676543582,"eps":-0.020583,"marketStatus":"Closed","change":-0.003,"latestTime":"04-23 16:12:00 AEST","open":0.062,"high":0.063,"low":0.061,"amount":5623,"amplitude":0.03125,"askPrice":0.064,"askSize":129999,"bidPrice":0.061,"bidSize":3650,"shortable":3,"etf":0,"ttmEps":-0.020583,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.064,"openAndCloseTimeList":[[1745366400000,1745388000000]],"volumeRatio":0.065415,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSX.AU\",,,,,undefined,":{"symbol":"BSX.AU","floatShares":455794853,"roa":"-11.34%","roe":"-61.38%","lyrEps":-0.035498,"volumeRatio":0.065415,"shares":676543582,"dividePrice":0,"high":0.063,"amplitude":0.03125,"preClose":0.064,"low":0.061,"week52Low":0.025,"pbRate":"2.48","psRate":"36.85","week52High":0.087,"institutionHeld":0,"latestPrice":0.061,"committee":-0.945379,"eps":-0.020583,"divideRate":0,"volume":89992,"delay":0,"ttmEps":-0.020583,"open":0.062,"prevYearClose":0.028,"prevWeekClose":0.062,"prevMonthClose":0.079,"prevQuarterClose":0.079,"fiveDayClose":0.063,"twentyDayClose":0.073,"sixtyDayClose":0.027},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BSX.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2491658551","title":"Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2491658551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491658551?lang=en_us&edition=fundamental","pubTime":"2024-12-14 05:30","pubTimestamp":1734125405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241213:nTUA7TR3DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","BSL","BSX.AU","BGB","BGX"],"gpt_icon":0},{"id":"2488509209","title":"Blackstone Minerals Ltd-Accelerated Non-Renounceable Entitlement Offer Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2488509209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488509209?lang=en_us&edition=fundamental","pubTime":"2024-12-03 14:38","pubTimestamp":1733207928,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUE1XYKGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSX.AU","BK7095"],"gpt_icon":0},{"id":"2486868930","title":"Boston Scientific to Buy Intera Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2486868930","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486868930?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:50","pubTimestamp":1732539046,"startTime":"0","endTime":"0","summary":"Boston Scientific  said Monday it has agreed to buy medical device company Intera Oncology for an undisclosed sum.The deal, which will likely close in H1 2025, is expected to have an immaterial effect on adjusted earnings in 2025 and be more dilutive on a GAAP basis owing to acquisition-related net charges and amortization expense, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2506951875.HKD","LU1989764748.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU0823416689.USD","LU2362541513.USD","LU1989771016.USD","LU2491050154.USD","BK4588","LU0353189763.USD","IE00BJT1NW94.SGD","LU2491049909.HKD","LU0011850046.USD","LU0823417653.USD","BK4082","LU0114720955.EUR","IE0009355771.USD","LU2087625088.SGD","BK4581","LU0528227936.USD","BSX.AU","LU0238689110.USD","LU0345769631.USD","LU2506952170.USD","LU2362541273.HKD","LU0187121727.USD","LU0122379950.USD","IE0002141913.USD","LU0950375773.USD","BK7095","LU2244417387.USD","LU1983299246.USD","BK4585","IE00B4R5TH58.HKD","LU0048584097.USD","LU0353189680.USD","LU0823417737.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","BSX","LU1791710582.SGD","LU0345769128.USD","LU2112291526.USD","LU2265009873.SGD","LU0267386448.USD","LU0077335932.USD","LU2491050071.SGD","LU2506951958.HKD","LU2242649171.HKD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2484923319","title":"BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX","url":"https://stock-news.laohu8.com/highlight/detail?id=2484923319","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484923319?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:22","pubTimestamp":1732022520,"startTime":"0","endTime":"0","summary":"Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global clinical trial for its WATCHMAN FLX Left Atrial Appendage Closure  device. The trial data provided clinical evidence indicating that LAAC with the WATCHMAN FLX device is safe and superior to oral anticoagulation  therapy for reducing the risk of long-term bleeding events in patients who have undergone an ablation.The OPTION trial data were presented at the American Heart Association's Scientific Sessions 2024 and published in the New England Journal of Medicine.In addition to the OPTION trial, the WATCHMAN technology is being evaluated against DOAC therapy in lower-risk patients within the CHAMPION-AF randomized trial. The latest-generation WATCHMAN FLX Pro LAAC device is similarly being studied in several clinical trials, including the SIMPLAAFY randomized controlled t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vZlajmbYZzKfSC9h66RaJg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vZlajmbYZzKfSC9h66RaJg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bsx-stock-gains-positive-option-132200283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU2065732104.USD","BK7095","LU2087625088.SGD","IE00BLDYK493.USD","LU0048584097.USD","LU1804176565.USD","LU1989772840.SGD","RMD","LU1153585028.USD","LU0187121727.USD","BK4082","LU0122379950.USD","BK4581","GMED","LU2112291526.USD","LU2242649171.HKD","IE00B2B36J28.USD","LU0106261612.USD","LU0345769128.USD","LU1989764748.USD","BSX","IE00BJJMRZ35.SGD","LU2324357040.USD","LU0267386448.USD","LU0528227936.USD","BK7501","IE0009355771.USD","LU0266013472.USD","LU2491050071.SGD","RMD.AU","HAE","LU2491049909.HKD","IE0009354923.USD","IE00B64QTZ34.USD","LU0205194284.USD","LU0823416689.USD","LU2265009873.SGD","LU2506952170.USD","BK4131","FLX","LU2008162690.USD","LU0012050646.USD","LU1061106388.HKD","LU2506952097.USD","LU1983299246.USD","LU2506951958.HKD","BSX.AU","LU0950375773.USD","LU2362540622.SGD","LU1718418525.SGD"],"gpt_icon":1},{"id":"2484995096","title":"Boston Sci stock climbs 5% on positive Watchman FLX data","url":"https://stock-news.laohu8.com/highlight/detail?id=2484995096","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484995096?lang=en_us&edition=fundamental","pubTime":"2024-11-19 01:37","pubTimestamp":1731951423,"startTime":"0","endTime":"0","summary":"Sundry Photography/iStock Editorial via Getty Images Boston Scientific  stock climbed 5% Monday after the medical device maker announced a study has shown its Watchman FLX device was superior to oral anti-coagulant medication in reducing bleeding risks following cardiac ablation.  The study also showed the Watchman FLX Left Atrial Appendage Closure, or LAAC, Device was as effective as oral anticoagulants in patients with atrial fibrillation following cardiac ablation, according to a statement released over the weekend. The clinical study, called OPTION, compared the Watchman FLX to direct oral anticoagulants and warfarin for the reduction of stroke risk in patients with non-valvular atrial fibrillation following cardiac ablation.  The trial met the primary safety endpoint of non-procedural major bleeding or clinically relevant non-major bleeding at 36 months and the primary efficacy endpoint of all-cause death, stroke or systemic embolism at 36 months, the company said. Boston Sci  pre","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182574929/image_1182574929.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182574929/image_1182574929.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4303450-boston-sci-stock-climbs-on-positive-watchman-flx-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["LU2506951958.HKD","LU1023059063.AUD","LU0077335932.USD","FLX","LU2362541513.USD","IE0002141913.USD","LU0267386448.USD","LU1153585028.USD","LU2112291526.USD","LU2242649171.HKD","LU2244417387.USD","LU0114720955.EUR","BK4588","BSX.AU","LU2087625088.SGD","BK4082","BSX","LU2324357040.USD","IE00B2B36J28.USD","BK7095","LU0266013472.USD","LU0528227936.USD","LU0353189680.USD","LU1791710400.SGD","LU0187121727.USD","LU0238689110.USD","LU1718418525.SGD","LU2491049909.HKD","IE00B4R5TH58.HKD","LU1791710582.SGD","LU2491050154.USD","LU0048584097.USD","LU0823416689.USD","LU2265009873.SGD","BK4131","IE00BJT1NW94.SGD","IE0009355771.USD","LU1989772923.USD","IE00BFTCPJ56.SGD","LU1989772840.SGD","LU1989771016.USD","BK4581","LU0823417737.USD","LU2506952170.USD","LU0950375773.USD","IE00BJJMRZ35.SGD","LU2491050071.SGD","LU1057294990.SGD","LU1983299246.USD","LU2362541273.HKD"],"gpt_icon":0},{"id":"2483586617","title":"Blackstone Credit & Insurance Closed-End Funds Announce Trustee, Officer, and Portfolio Management Team Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2483586617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483586617?lang=en_us&edition=fundamental","pubTime":"2024-11-16 02:56","pubTimestamp":1731696961,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUA3KQHZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSL","BGB","BK7095","BSX.AU","BGX"],"gpt_icon":0},{"id":"2483714193","title":"Boston Scientific Completes Acquisition of Axonics","url":"https://stock-news.laohu8.com/highlight/detail?id=2483714193","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483714193?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:00","pubTimestamp":1731679229,"startTime":"0","endTime":"0","summary":"Boston Scientific  said Friday that it completed the acquisition of Axonics , a medical technology company specializing in devices for urinary and bowel dysfunction.The company said the deal, which has an equity value of $3.7 billion and an enterprise value of $3.3 billion, is expected to be immaterial to adjusted earnings per share in 2024 and 2025 and become accretive afterward.Boston Scientific also said that the deal is slated to be less accretive on a GAAP basis due to amortization and acquisition-related costs.Price: 87.12, Change: -0.47, Percent Change: -0.54","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","LU1791710582.SGD","BSX.AU","IE00B4R5TH58.HKD","LU2506952170.USD","LU0353189763.USD","LU1153585028.USD","LU2362540622.SGD","LU2362541273.HKD","LU1989764664.SGD","LU1291159041.SGD","LU0823417737.USD","LU1791710400.SGD","LU2265009873.SGD","LU0823416689.USD","LU2491050071.SGD","LU2491049909.HKD","LU1989764748.USD","BK4082","LU0353189680.USD","LU1989772923.USD","LU2087625088.SGD","LU1989772840.SGD","LU0077335932.USD","LU1023059063.AUD","LU1061106388.HKD","BK4585","LU0267386448.USD","LU0950375773.USD","LU0882574055.USD","LU0823417653.USD","LU0528227936.USD","LU2112291526.USD","LU0048584097.USD","LU1989771016.USD","BSX","LU0122379950.USD","IE00BJT1NW94.SGD","BK4504","IE0009355771.USD","IE00B2B36J28.USD","AXNX","LU0266013472.USD","LU1804176565.USD","LU2242649171.HKD","LU0345769631.USD","LU2506951875.HKD","LU0187121727.USD","LU2506951958.HKD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2483338319","title":"Axonics gains after Nasdaq delisting notice for sale to Boston Scientific","url":"https://stock-news.laohu8.com/highlight/detail?id=2483338319","media":"seekingalpha","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483338319?lang=en_us&edition=fundamental","pubTime":"2024-11-15 02:15","pubTimestamp":1731608138,"startTime":"0","endTime":"0","summary":"Sundry Photography/iStock Editorial via Getty Images Axonics  quickly edged higher by 0.8% after a Nasdaq delisting notice for its planned sale to Boston Scientific . The deal is tentatively scheduled to close prior to the market open on Friday and the stock will be halted after hours","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182574929/image_1182574929.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182574929/image_1182574929.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4291495-axonics-gains-after-nasdaq-delisting-notice-for-sale-to-boston-scientific","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["BK4585","BSX.AU","LU2506951958.HKD","NDAQ","LU1023059063.AUD","BSX","LU2362541513.USD","LU2244417387.USD","BK4082","LU2095319765.USD","LU0251132253.USD","LU0114720955.EUR","LU0267386448.USD","LU1791710400.SGD","LU2210149790.SGD","LU0823417653.USD","AXNX","LU0823416689.USD","BK4581","LU2491049909.HKD","LU2324357040.USD","IE00BJJMRZ35.SGD","NQmain","LU0238689110.USD","LU0353189680.USD","LU2210150020.SGD","TQQQ","QLD","BK4504","PSQ","LU0011850046.USD","QID","LU0823417737.USD","IE00B64PRP62.GBP","LU0048584097.USD","IE00BJT1NW94.SGD","SQQQ","LU0882574055.USD","LU0950375773.USD","LU2087625088.SGD","LU1983299246.USD","IE0002141913.USD","LU1718418525.SGD","MNQmain","LU2112291526.USD","LU2506951875.HKD","IE00B2B36J28.USD",".IXIC","LU0345769128.USD"],"gpt_icon":0},{"id":"2481562693","title":"Q3 2024 Black Stone Minerals LP Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2481562693","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481562693?lang=en_us&edition=fundamental","pubTime":"2024-11-06 15:36","pubTimestamp":1730878593,"startTime":"0","endTime":"0","summary":"Thomas L Carter; Chairman, CEO and President; Black Stone Minerals LP. Thanks, Mark, good morning and thanks for joining us today. We had a successful third quarter and as previously announced, maintained our consistent distribution despite a decrease in production from last quarter driven by volatility in the natural gas area throughout the year. During the quarter, we progressed our minimal acquisition program and we continue working with our partners for long term development. We remain confident in the outlook across our acreage position and are focused on our targeted acquisition strategy to further enhance our existing long runway of high interest development opportunities on the acquisition front. We continue to expand our asset footprint through the targeted grassroots acquisition program. We've previously discussed throughout the year during the quarter, we added about $15 million in minerals and royalty assets along with a substantial lease, all of which further build a conti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q3-2024-black-stone-minerals-073633727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BSX.AU","BSM"],"gpt_icon":0},{"id":"2480584283","title":"Boston Scientific to Acquire Medical Technology Firm Cortex","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584283","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480584283?lang=en_us&edition=fundamental","pubTime":"2024-11-04 23:02","pubTimestamp":1730732572,"startTime":"0","endTime":"0","summary":"Boston Scientific  said Monday it has agreed to acquire Cortex, a privately-held medical technology firm.The transaction is expected to close in H1 2025, subject to customary conditions, Boston Scientific said, adding that the deal is projected to have minimal impact on its 2025 adjusted earnings per share.Financial terms were not disclosed.Boston Scientific shares were up 1.6% in recent trading.Price: 84.99, Change: +1.37, Percent Change: +1.64","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1718418525.SGD","LU1804176565.USD","LU0266013472.USD","LU2506952170.USD","BK4581","LU1023059063.AUD","LU2506951875.HKD","LU1989771016.USD","BSX","LU0011850046.USD","LU0345769631.USD","LU1983299246.USD","LU0950375773.USD","LU2362541513.USD","BK7095","IE00BFTCPJ56.SGD","LU1791710400.SGD","LU1989764748.USD","LU1989764664.SGD","LU2112291526.USD","LU2265009873.SGD","LU0251132253.USD","LU2087625088.SGD","LU2506951958.HKD","BSX.AU","LU0528227936.USD","LU0048584097.USD","IE00B2B36J28.USD","LU2491050071.SGD","LU2491050154.USD","LU0345769128.USD","LU1061106388.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0238689110.USD","LU0187121727.USD","LU0353189763.USD","BK4082","LU0077335932.USD","LU0353189680.USD","LU1791710582.SGD","BK4588","LU0882574055.USD","LU2324357040.USD","IE00B4R5TH58.HKD","LU0823417737.USD","LU1153585028.USD","LU0823416689.USD","LU2362541273.HKD"],"gpt_icon":0},{"id":"2480805265","title":"QGEN Stock Set to Gain From FDA's Clearance of QIAstat-Dx Mini Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2480805265","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480805265?lang=en_us&edition=fundamental","pubTime":"2024-11-04 22:31","pubTimestamp":1730730660,"startTime":"0","endTime":"0","summary":"QIAGEN N.V.QGEN recently achieved FDA clearance for its QIAstat-Dx Respiratory Panel Mini test for clinical use. This is the second QIAstat-Dx respiratory panel to receive U.S. regulatory nod this year.The QIAstat-Dx Respiratory Panel Mini offers a streamlined approach for diagnosing the five most actionable pathogens causing upper respiratory infections: influenza A, influenza B, human rhinovirus, respiratory syncytial virus  and SARS-CoV-2. This is more targeted than the comprehensive 21-target QIAstat-Dx Respiratory Panel Plus, which is highly suitable for hospitalized patients with risk factors for severe disease.Since the news was released on Oct. 29, QIAGEN’s shares have jumped 3.1% to close at $43.08 on Friday. The robust growth momentum in the QIAstat syndromic testing system is poised to continue, supported by new product launches in the United States. Accordingly, we expect market sentiment toward QGEN stock to remain positive surrounding this news.QIAGEN currently has a mark","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z2Y2lgbJQfUa74IVYcsxPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qgen-stock-set-gain-fdas-143100673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU0048584097.USD","LU1791710582.SGD","LU0238689110.USD","LU2491050071.SGD","LU1291159041.SGD","QGEN","LU2065732104.USD","LU0077335932.USD","LU1989764748.USD","LU2362541273.HKD","BK7501","LU1791710400.SGD","LU0353189763.USD","LU2362540622.SGD","BK4581","LU0251132253.USD","LU0122379950.USD","LU1989771016.USD","BK4585","BSX.AU","LU2324357040.USD","BK7095","LU2362541513.USD","LU2506951875.HKD","BK4567","BK4082","LU0528227936.USD","RMD.AU","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4588","LU1023059063.AUD","LU0011850046.USD","LU1983299246.USD","IE0009355771.USD","LU0353189680.USD","LU2506952097.USD","IE00BFTCPJ56.SGD","BK4121","IE0002141913.USD","LU1804176565.USD","LU1718418525.SGD","RMD","LU2008162690.USD","LU1989772923.USD","LU0187121727.USD","LU1061106388.HKD","BSX","GMED"],"gpt_icon":0},{"id":"2480268316","title":"BRIEF-Blackstone Minerals Launches A$4M Accelerated Entitlement Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2480268316","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480268316?lang=en_us&edition=fundamental","pubTime":"2024-11-04 07:52","pubTimestamp":1730677979,"startTime":"0","endTime":"0","summary":"Nov 4  - Blackstone Minerals Ltd   :   * BLACKSTONE UNDERTAKING AN ACCELERATED NON-RENOUNCEABLE PRO RATA ENTITLEMENT OFFER TO RAISE UP TO A$4 MILLION   * ENTITLEMENT OFFER AT A$0.03/NEW SHARE   * ALL CURRENCIES REPRESENTED IN AUDFurther company coverage:    ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX.AU","BK7095"],"gpt_icon":0},{"id":"2480631623","title":"Blackstone Minerals Ltd-Entitlement Offer Prospectus","url":"https://stock-news.laohu8.com/highlight/detail?id=2480631623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480631623?lang=en_us&edition=fundamental","pubTime":"2024-11-04 07:50","pubTimestamp":1730677854,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241103:nTUE4XXLR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BSX.AU","BK7095"],"gpt_icon":0},{"id":"2480631622","title":"Blackstone Minerals - All Currencies Represented in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2480631622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480631622?lang=en_us&edition=fundamental","pubTime":"2024-11-04 07:50","pubTimestamp":1730677833,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241103:nTUE8NRVLL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","BSX.AU"],"gpt_icon":0},{"id":"2480488641","title":"PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2480488641","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480488641?lang=en_us&edition=fundamental","pubTime":"2024-11-01 19:41","pubTimestamp":1730461260,"startTime":"0","endTime":"0","summary":"Phibro Animal Health Corporation PAHC recently completed the acquisition of Zoetis Inc.’s ZTS medicated feed additive  product portfolio and certain water-soluble products. The latest acquisition comes with a lineup of products across cattle, swine and poultry, which will complement and expand Phibro’s species and product portfolios. This will help the company’s customers meet the highest standards of animal care, prevent diseases and enhance nutrition around the world.Subsequent to the news, the share price of PAHC remained unchanged at $23.12 at yesterday’s aftermarket trading.The acquired product portfolio is expected to boost Phibro’s profitability and EBITDA margin and be accretive to its adjusted earnings per share. From investors’ viewpoint, the latest acquisition should expand and diversify Phibro’s revenue base, ultimately generating funds to support future investments in additional fast-growing animal health product categories. We expect the market sentiment to improve around","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pahc-stock-likely-gain-latest-114100768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["GMED","BK4110","LU2506952097.USD","LU2177674079.SGD","LU0158827948.USD","LU1989772840.SGD","LU0077335932.USD","IE00B4R5TH58.HKD","LU2028103732.USD","LU2087625088.SGD","BK4581","CAGR","LU2242649171.HKD","IE00BJT1NW94.SGD","RMD.AU","ZTS","LU1989772923.USD","BSX.AU","LU2362541273.HKD","BK7501","LU0345774631.USD","LU0238689110.USD","LU2271345857.HKD","BK7007","LU2244417387.USD","LU2491050071.SGD","LU1057294990.SGD","LU0011850046.USD","LU2324357040.USD","BK4534","LU2112291526.USD","BK4567","LU1989771016.USD","LU1791710400.SGD","RMD","LU2111349929.HKD","LU0353189763.USD","LU1989764748.USD","LU0345774391.USD","PAHC","BK4504","LU0471298777.SGD","LU2506951875.HKD","BSX","LU2362540622.SGD","LU2089283258.USD","LU2506952170.USD","MFA","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2479790370","title":"BRIEF-Blackstone Minerals Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2479790370","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479790370?lang=en_us&edition=fundamental","pubTime":"2024-10-31 09:11","pubTimestamp":1730337085,"startTime":"0","endTime":"0","summary":"Oct 31 (Reuters) - Blackstone Minerals Ltd   :   * SEEKS TRADING HALT PENDING ANNOUNCEMENT ON ENTITLEMENT OFFERFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX.AU","BK7095"],"gpt_icon":0},{"id":"2477155211","title":"Sector Update: Health Care Stocks Retreat in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2477155211","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477155211?lang=en_us&edition=fundamental","pubTime":"2024-10-24 01:56","pubTimestamp":1729706181,"startTime":"0","endTime":"0","summary":"Health care stocks fell Wednesday afternoon, with the NYSE Health Care Index shedding 0.7% and the Health Care Select Sector SPDR Fund  down 0.8%.The iShares Biotechnology ETF  declined 1.4%.In corporate news, Lumos Pharma  shares jumped 7.2% after the company agreed to be acquired by a unit of Double Point Ventures.Fortrea  shares popped 2.5% after media reports said that activist investor Corvex Management acquired a stake in the contract research firm.Boston Scientific  raised its 2024 guidance on Wednesday after logging stronger-than-expected growth in Q3 results. Its shares were falling 1.2%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1804176565.USD","IE00BFTCPJ56.SGD","LU0353189763.USD","BK7095","IBB","IE00BJT1NW94.SGD","LU0266013472.USD","LU2491049909.HKD","LU2362541273.HKD","LU0238689110.USD","LU2087625088.SGD","BSX.AU","IE00B2B36J28.USD","LU0345769128.USD","LU1791710582.SGD","LU2506952170.USD","LU1061106388.HKD","BK4139","LU0122379950.USD","BK4581","BK4588","LU0187121727.USD","LU1989772840.SGD","LU1791710400.SGD","LU1057294990.SGD","LU2506952097.USD","LU0823417737.USD","LU1989764748.USD","LU0353189680.USD","LU2112291526.USD","BK4585","LUMO","BK4082","LU2506951958.HKD","IE0009355771.USD","FTRE","LU1989771016.USD","IE00BJJMRZ35.SGD","BSX","LU0114720955.EUR","LU1983299246.USD","LU0950375773.USD","LU2242649171.HKD","LU2244417387.USD","LU0267386448.USD","LU2362541513.USD","XLV","LU1989772923.USD","LU2506951875.HKD","LU0011850046.USD"],"gpt_icon":0},{"id":"2476293212","title":"Boston Scientific Gets FDA Approvals for 2 New Cardiac Mapping Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2476293212","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476293212?lang=en_us&edition=fundamental","pubTime":"2024-10-19 04:52","pubTimestamp":1729284720,"startTime":"0","endTime":"0","summary":"Boston Scientific  said Friday the US Food and Drug Administration approved the Farawave NAV ablation catheter for the treatment of paroxysmal atrial fibrillation.The FDA also issued a 510 clearance for the company's Faraview software that magnetically tracks the Farawave catheter. The two technologies, in combination with the company's OPAL HD mapping system, will provide visualization for cardiac ablation procedures with its Farapulse pulsed field ablation system, Boston Scientific said.The company plans to will launch technologies immediately in the US.Price: 89.11, Change: +1.04, Percent Change: +1.18","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2362541513.USD","BK4082","LU2506951958.HKD","LU0251132253.USD","LU1718418525.SGD","LU2087625088.SGD","BSX","LU0114720955.EUR","LU0122379950.USD","LU1989772840.SGD","LU0011850046.USD","LU0950375773.USD","LU2362540622.SGD","LU0823417737.USD","LU2112291526.USD","LU2362541273.HKD","LU0823417653.USD","LU0823416689.USD","IE00B2B36J28.USD","LU0353189680.USD","BK4588","LU1791710582.SGD","LU2324357040.USD","LU1989772923.USD","LU2506952170.USD","BSX.AU","LU1791710400.SGD","LU0077335932.USD","LU0266013472.USD","LU1989764664.SGD","LU1023059063.AUD","LU0345769631.USD","BK4585","LU2242649171.HKD","LU2265009873.SGD","LU0187121727.USD","IE00BJT1NW94.SGD","LU2506951875.HKD","LU0238689110.USD","IE0002141913.USD","LU0353189763.USD","IE0009355771.USD","LU1989764748.USD","LU0528227936.USD","LU0267386448.USD","LU0882574055.USD","BK7095","IE00B4R5TH58.HKD","LU2491049909.HKD","LU1989771016.USD"],"gpt_icon":0},{"id":"2476268706","title":"Oppenheimer buy-rated ideas: BSX, MDT, and one hold: CYTK","url":"https://stock-news.laohu8.com/highlight/detail?id=2476268706","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476268706?lang=en_us&edition=fundamental","pubTime":"2024-10-18 23:21","pubTimestamp":1729264883,"startTime":"0","endTime":"0","summary":"ArtistGNDphotography Oppenheimer analysts highlighted two buy-rated stocks and one hold-rated. In a technical analysis note, analysts gave some “technical color” for three stocks discussed on a research call: Boston Scientific Corp. (BSX)  The stock shows one of the strongest trends in","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1368363817/image_1368363817.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1368363817/image_1368363817.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4175508-oppenheimer-buy-rated-ideas-bsx-mdt-and-one-hold-cytk","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["LU1804176565.USD","LU1989764664.SGD","LU0353189763.USD","LU2089284900.SGD","BK7095","IE00BJT1NW94.SGD","LU2491049909.HKD","LU2362541273.HKD","BSX.AU","LU1023059063.AUD","LU1061106388.HKD","MDT","LU0122379950.USD","LU2023251221.USD","LU0528227936.USD","BK4127","LU0251132253.USD","LU1989772840.SGD","LU0211326839.USD","IE0002141913.USD","CYTK","LU1057294990.SGD","LU0823417737.USD","LU1989764748.USD","LU2028103732.USD","LU2362540622.SGD","LU2491050154.USD","LU0353189680.USD","LU2112291526.USD","BK4082","LU0211331839.USD","OPY","LU1989771016.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","BSX","LU2089283258.USD","LU1983299246.USD","LU0950375773.USD","LU2242649171.HKD","LU0211326755.USD","LU2491050071.SGD","LU2244417387.USD","LU0267386448.USD","LU2362541513.USD","BK4533","LU1571399168.USD","LU1989772923.USD","BK4566","LU0882574055.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BSX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BSX.AU\",market:\"AU\",,,undefined,":[]}}